Curi Revenue and Competitors

Location

N/A

Total Funding

Finance

Industry

Estimated Revenue & Valuation

  • Curi's estimated annual revenue is currently $90.8M per year.(i)
  • Curi's estimated revenue per employee is $262,500

Employee Data

  • Curi has 346 Employees.(i)
  • Curi grew their employee count by 18% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A24588-13%N/AN/A
#2
$16.4M78-7%N/AN/A
#3
$4.1M28-22%N/AN/A
#4
$2.9M20-9%N/AN/A
#5
$498.6M169614%N/AN/A
#6
$37M16022%N/AN/A
#7
$0.5M50%N/AN/A
#8
$101.1M385-1%N/AN/A
#9
$143.1M54571%N/AN/A
#10
$608.3M20695%N/AN/A
Add Company

Curi is committed to helping physicians in medicine, business, and life. Founded in 1975, we were built on a promise: When doctors needed help, we would answer the call. Physicians? needs have changed over the years, but our dedication to that promise has never wavered. From medical malpractice insurance to wealth management to well-being programs, we remain passionately curious about meeting the ever-evolving needs of physicians and those who support them.

keywords:N/A

N/A

Total Funding

346

Number of Employees

$90.8M

Revenue (est)

18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Curi's People

NameTitleEmail/Phone
1
Integration SpecialistReveal Email/Phone
2
UnderwriterReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
HR GeneralistReveal Email/Phone
5
Talent Acquisition LeaderReveal Email/Phone
6
Business Development LeaderReveal Email/Phone
7
PrincipalReveal Email/Phone
8
Project Director Client Operations-Curi AdvisoryReveal Email/Phone
9
Office Services CoordinatorReveal Email/Phone
10
Senior Claims ExaminerReveal Email/Phone

Curi News

2022-04-17 - Zacks: Analysts Expect CuriosityStream Inc. (NASDAQ:CURI ...

Zacks: Analysts Expect CuriosityStream Inc. (NASDAQ:CURI) Will Announce Earnings of -$0.35 Per Share. Posted by admin on Apr 18th, 2022.

2022-04-17 - CuriosityStream: Checking Out Yet Another SPAC Disaster

(NASDAQ:CURI). As can be seen by the chart above, the company and the stock have not lived up to their initial hyperbole. Are the shares now...

2022-03-22 - Curi Bio Acquires CarTox™ Technology from StemBioSys ...

In parallel, Curi Bio announced it will commercialize the technology through its newly announced product: the Nautilus™ optical mapping system.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$75.5M347-1%N/A
#2
$121.8M3615%N/A
#3
$35M3625%N/A
#4
$66.2M3657%N/A
#5
N/A3728%N/A